Diazepam Supplier CAS 439-14-5 Ro 5-2807 Tocris Bioscience

8.23.2018 author Jasmine Jeff

View and buy high purity Diazepam from Tocris Bioscience. Acts at the benzodiazepine modulatory site. Cited in 7 publications.

Huang et al (2010) A refractory period for rejuvenating GABAergic synaptic transmission and ocular dominance plasticity with dark exposure. J Neurosci 30 16636 PMID:.

Our Pain guide highlights over 280 products for Pain research.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image.

Zhu (2018) Structure of a human synaptic GABAA receptor. Nature 559 67 PMID:.

Written by Ian Martin, Norman Bowery and Susan Dunn, this review provides a history of the GABA receptor, as well as discussing the structure and function of the various subtypes and the clinical potential of receptor modulators; compounds available from Tocris are listed.

Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.


6.21.2018 author Zachary Arnold

Diazepam; CAS Number: ; EC Number: ; Synonym: 7-Chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2(1H)-one, Ro 5-2807; Linear.

Benzodiazepine anxiolytic; prototype ligand for the GABA A receptor benzodiazepine modulatory site.

Site Use Terms| Privacy. 2018 Merck KGaA, Darmstadt, Germany and/or its affiliates. Sigma-Aldrich Products are sold exclusively through Sigma-Aldrich, Inc. Reproduction of any materials from the site is strictly forbidden without permission.

Synonym: 7- Chloro- 1- methyl- 5- phenyl- 3H- 1,4- benzodiazepin- 2(1H) - one, Ro 5-2807 CAS Number.

Need larger quantities for your development, manufacturing or research applications?

Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm. Click here to discover more featured Neuroscience products. This compound is a featured product for Neuroscience research.

To browse other handbook pages, click here. This compound is featured on the GABAA Receptors page of the Handbook of Receptor Classification and Signal Transduction.

PubChem Substance ID.

Pricing & availability is not currently available. Questions? Contact Technical Service.

D0899 - Diazepam.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

This compound was developed by Roche. Certificate of Analysis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Keywords: Bioactive small molecules, Central Nervous System, Diseases, Metabolism, Neurodegenerative Diseases, Neuroscience, Neurotransmission, Neurotransmitters. The nervous system, comprised of the brain and spinal cord (central nervous system, or CNS) and network of nerves that connects the CNS to the rest of the body (peripheral nervous system, or PNS) is.

Empirical Formula (Hill Notation) C 16 H 13 ClN 2 O Molecular Weight 284.74 EC Number MDL number MFCD.

Diazepam for treating tetanus

4.19.2018 author Zachary Arnold

Diazepam for treating tetanus. Okoromah CN(1), Lesi FE. Author information: (1)Paediatrics and Child Health, College of Medicine of the University of Lagos.

We searched the Cochrane Neonatal Group trials register (October 2003), Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 3, 2003), MEDLINE (1966 to October 2003), EMBASE (1980 to October 2003), LILACS (2003), CINAHL (October 2003), Science Citation Index, African Index Medicus, conference abstracts and reference lists of articles. We contacted researchers, experts and organizations working in the field and used personal communication.

Diazepam compared to other drugs (eg phenobarbitone and chlorpromazine) may have advantages because of combined anticonvulsant, muscle relaxant, sedative and anxiolytic effects.

Diazepam affects both level and amplitude of rat locomotor activity

3.18.2018 author Hunter Murphy

Chronobiol Int. 2005;22(6):975-85. Diazepam affects both level and amplitude of rat locomotor activity rhythm but has no effect on core body temperature.

Generate a file for use with external citation management software.

Warning: The NCBI web site requires JavaScript to function. more.

Diazepam lacked effect on body core temperature even on the first day of administration, thereby ruling out the possibility of drug tolerance development. Diazepam exerted no effects on the length of the period and did not affect the phase of the locomotor activity rhythm. Diazepam was administered subcutaneously for 3 wks in a dosage of 3 mg/kg body weight/day, 1 h before the onset of darkness. The fact that diazepam affects locomotor activity, but not core body temperature, suggests that different mechanisms mediate the actions of diazepam on locomotor activity and on core body temperature. The present study investigates the effects of a chronic administration of diazepam, a benzodiazepine widely used as an anxiolytic, on locomotor activity and body core temperature rhythms in male Wistar rats housed under 12 : 12 light : dark (LD) cycle conditions. The body temperature rhythm of rats was affected neither by short-term (a single injection) nor by long-term (every day for 3 wks) diazepam treatment. Diazepam increased the level of locomotor activity from the first day until the end of treatment, and also increased the amplitude of the activity circadian rhythm, but only on the third wk of treatment.

National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA. National Center for Biotechnology Information, U.S.

Functional and biochemical evidence for diazepam as a cyclic

12.27.2018 author Jasmine Jeff

Br J Pharmacol. 1998 Mar;123(6):1047-54. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.

more. Warning: The NCBI web site requires JavaScript to function.

This effect of diazepam was not gamma-aminobutyric acid (GABA)-dependent, since it was neither mimicked nor potentiated by GABA, and was not affected by either a high concentration (5 microM) of the antagonists of the benzodiazepine/GABA/channel chloride receptor complex, picrotoxin, flumazenil and beta-carboline-3-carboxylic acid methyl ester (betaCCMe), or by the inverse agonists, beta-carboline-3-carboxylic acid N-methylamide (betaCCMa) and methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM, 0.1 microM).